Atlas Trials

Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia

Clinical trial NCT01047592 · COMPLETED

Trial details

NCT number
NCT01047592
Sponsor
Chang-Hua Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-03-01
Primary completion
2013-12-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.